KPTI Estadísticas clave
Alto
7.16
Abrir
7.14
Volumen
149.13K
Bajo
6.88
Cierre anterior
7.18
Valor negociado
1.04M
Máx. 52 sem.
10.99
Volumen rel.
0.228
Amplitud (%)
3.83%
Mín. 52 sem.
3.65
Tasa de rotación
0.66%
Cap. de Mercado
162.71M
PER (TTM)
--
PER (Anual)
--
P/B
-0.61
P/S
1.08
Beneficio por acción (BPA)
-15.087
Dividendo (TTM)
0
Rentabilidad por dividendo
0.00%
Acciones en circulación
22.66M
Moneda
USD
KPTI Rendimiento del Precio
7 día
30 día
90 día
180 día
En lo que va del año
1 Año
KPTI Distribución del flujo de dinero
KPTI Volumen diario de ventas en corto
KPTI Historial de short interest
Resumen de la acción KPTI
As of 2026-07-23, the Karyopharm Therapeutics Inc. (KPTI) stock price today is 6.98. Based on this price, the company has a market capitalization of $162.71M, with a P/E ratio of --.
On 2026-07-23, KPTI traded between 6.88 and 7.16. Today’s stock price is 1.45% above the daily low and 2.51% below the daily high, placing KPTI dentro del rango inferior de its most recent trading range.
Trading volume currently stands at 149.13K, compared with an average daily volume of 652.80K. This suggests that trading activity is significativamente por debajo de su nivel habitual than usual.
Over the past year, Karyopharm Therapeutics Inc. shares have traded between 3.65 and 10.99. At today’s price, KPTI is 91.23% above its 52-week low and 36.49% below its 52-week high.
KPTI Noticias relacionadas
Acerca de KPTI
Nombre empresa
Karyopharm Therapeutics Inc.
Sector
Health Technology
Industria
Pharmaceuticals: Major
Intercambios
Nasdaq
Número de empleados
228
Tamaño del lote
100
Sitio oficial
Moneda
USD
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).
Related Stocks
KPTI FAQ
© 2026 CoinGlass, all rights reserved
